BEAM
Price
$21.38
Change
-$0.22 (-1.02%)
Updated
Apr 26, 6:59 PM EST
9 days until earnings call
DNLI
Price
$15.43
Change
+$0.47 (+3.14%)
Updated
Apr 26, 6:59 PM EST
4 days until earnings call
Ad is loading...

Analysis and predictions BEAM vs DNLI

Header iconBEAM vs DNLI Comparison
Open Charts BEAM vs DNLIBanner chart's image
Beam Therapeutics
Price$21.38
Change-$0.22 (-1.02%)
Volume$713.48K
CapitalizationN/A
Denali Therapeutics
Price$15.43
Change+$0.47 (+3.14%)
Volume$746.76K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs DNLI Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. DNLI commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and DNLI is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (BEAM: $21.38 vs. DNLI: $15.43)
Brand notoriety: BEAM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. DNLI: 90%
Market capitalization -- BEAM: $1.76B vs. DNLI: $2.2B
BEAM [@Biotechnology] is valued at $1.76B. DNLI’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $568.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while DNLI’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 4 bearish.
  • DNLI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BEAM and DNLI are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -10.54% price change this week, while DNLI (@Biotechnology) price change was -3.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

DNLI is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for DNLI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DNLI($2.2B) has a higher market cap than BEAM($1.76B). BEAM YTD gains are higher at: -21.455 vs. DNLI (-28.099).
BEAMDNLIBEAM / DNLI
Capitalization1.76B2.2B80%
EBITDAN/AN/A-
Gain YTD-21.455-28.09976%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDNLI
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MICSX12.720.07
+0.55%
Matthews Asian Growth & Income Instl
WCMFX12.860.07
+0.55%
WCM SMID Quality Val Fd Institutional
AWPYX19.160.08
+0.42%
AB Sustainable Intl Thematic Advisor
VMIDX25.650.07
+0.27%
VALIC Company I Mid Cap Index
OIEFX23.28-0.02
-0.11%
JPMorgan Equity Income R2

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+3.14%
BEAM - DNLI
69%
Closely correlated
-1.02%
NTLA - DNLI
65%
Loosely correlated
+3.70%
JANX - DNLI
59%
Loosely correlated
+0.62%
XNCR - DNLI
51%
Loosely correlated
+3.90%
LGND - DNLI
51%
Loosely correlated
+0.28%
More